New Fortress Energy
NFE
Lantheus
LNTH
Dorian LPG
LPG
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
ONCO Onconetix
- 0.225
- -0.028-10.89%
Close Mar 4 16:00 ET
3.27MMarket Cap0.00P/E (TTM)
0.241High0.210Low960.92KVolume0.230Open0.253Pre Close214.68KTurnover10.23%Turnover Ratio0.00P/E (Static)14.55MShares21.40052wk High0.10P/B2.11MFloat Cap0.21052wk Low--Dividend TTM9.39MShs Float3636.000Historical High--Div YieldTTM12.12%Amplitude0.210Historical Low0.223Avg Price1Lot Size
About Onconetix Company
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Company Profile
SymbolONCO
Company NameOnconetix
Listing DateFeb 18, 2022
Founded2018
CEODr. Ralph Schiess
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address201 East 5th Street,Suite 1900
CityCincinnati
ProvinceOhio
CountryUnited States of America
Zip Code45202
Phone1-513-620-4101
Websitehttp://www.onconetix.com
Company Executives
- Name
- Position
- Salary
- Dr. Ralph Schiess
- Chief Executive Officer, Proteomedix AG
- --
- Karina M. Fedasz
- Interim Chief Financial Officer
- --
- James Sapirstein
- Executive Chairman of the Board
- 182.12K
- Dr. Thomas Meier, PhD
- Director
- --
- Andrew J. Oakley
- Director
- --
- Dr. Ajit Singh, PhD.
- Director
- --
- Timothy R. Ramdeen
- Independent Director
- 82.67K
- Simon Tarsh
- Independent Director
- 112.62K